AngioDynamics (ANGO) Competitors $8.65 -0.98 (-10.18%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$8.86 +0.21 (+2.38%) As of 08:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO vs. TMO, WST, IART, OFIX, SRDX, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "medical" sector. AngioDynamics vs. Its Competitors Thermo Fisher Scientific West Pharmaceutical Services Integra LifeSciences Orthofix Medical Surmodics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Thermo Fisher Scientific (NYSE:TMO) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Do analysts rate TMO or ANGO? Thermo Fisher Scientific presently has a consensus target price of $600.30, suggesting a potential upside of 43.50%. AngioDynamics has a consensus target price of $14.00, suggesting a potential upside of 61.85%. Given AngioDynamics' stronger consensus rating and higher possible upside, analysts plainly believe AngioDynamics is more favorable than Thermo Fisher Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Thermo Fisher Scientific 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.80AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in TMO or ANGO? 89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 5.4% of AngioDynamics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, TMO or ANGO? Thermo Fisher Scientific has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, AngioDynamics has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Does the media refer more to TMO or ANGO? In the previous week, Thermo Fisher Scientific had 60 more articles in the media than AngioDynamics. MarketBeat recorded 77 mentions for Thermo Fisher Scientific and 17 mentions for AngioDynamics. Thermo Fisher Scientific's average media sentiment score of 1.10 beat AngioDynamics' score of 0.36 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 48 Very Positive mention(s) 9 Positive mention(s) 12 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 2 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Is TMO or ANGO more profitable? Thermo Fisher Scientific has a net margin of 15.19% compared to AngioDynamics' net margin of -14.61%. Thermo Fisher Scientific's return on equity of 17.15% beat AngioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets Thermo Fisher Scientific15.19% 17.15% 8.47% AngioDynamics -14.61%-3.73%-2.43% Which has preferable earnings and valuation, TMO or ANGO? Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermo Fisher Scientific$42.88B3.68$6.34B$17.0524.53AngioDynamics$303.91M1.16-$184.35M-$1.01-8.56 SummaryThermo Fisher Scientific beats AngioDynamics on 12 of the 16 factors compared between the two stocks. Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$391.05M$6.76B$5.61B$9.29BDividend YieldN/A1.21%4.23%4.03%P/E Ratio-8.5625.9728.5419.58Price / Sales1.1661.69430.1194.56Price / Cash2.2520.3636.0257.93Price / Book1.694.638.145.54Net Income-$184.35M$174.76M$3.24B$257.73M7 Day Performance-10.27%-3.25%0.17%-0.08%1 Month Performance-19.98%-0.33%5.95%8.09%1 Year Performance15.18%0.36%26.22%13.02% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics3.9167 of 5 stars$8.65-10.2%$14.00+61.8%+45.9%$391.05M$303.91M-8.56760Trending NewsEarnings ReportGap UpHigh Trading VolumeTMOThermo Fisher Scientific4.9917 of 5 stars$418.76-2.5%$604.05+44.2%-23.1%$162.07B$42.88B24.56125,000Positive NewsUpcoming EarningsDividend AnnouncementWSTWest Pharmaceutical Services4.7899 of 5 stars$221.49-0.3%$320.00+44.5%-31.0%$15.97B$2.89B34.7710,600Positive NewsIARTIntegra LifeSciences4.1069 of 5 stars$12.75-5.5%$18.63+46.1%-60.7%$1.05B$1.61B-33.554,396OFIXOrthofix Medical2.9886 of 5 stars$10.72-3.6%$21.50+100.6%-31.9%$435.69M$799.49M-2.911,616Positive NewsSRDXSurmodics4.5221 of 5 stars$29.66-1.1%$43.00+45.0%-25.4%$428.83M$126.08M-21.34450ARAYAccuray2.5548 of 5 stars$1.34-5.6%N/A-30.7%$146.28M$446.55M0.001,040Positive NewsRMTIRockwell Medical3.991 of 5 stars$0.80-3.1%$4.00+401.9%-49.3%$28.12M$101.49M0.00300RSLSReShape Lifesciences0.6187 of 5 stars$2.38+0.4%N/A-99.2%$5.65M$8.01M-0.0150ABTAbbott Laboratories4.9474 of 5 stars$133.62-0.6%$142.61+6.7%+27.6%$233.90B$42.34B17.33114,000Trending NewsUpcoming EarningsAnalyst ForecastISRGIntuitive Surgical4.6536 of 5 stars$534.71-1.8%$588.95+10.1%+17.1%$195.15B$8.35B78.4015,638Positive NewsUpcoming EarningsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Thermo Fisher Scientific Competitors West Pharmaceutical Services Competitors Integra LifeSciences Competitors Orthofix Medical Competitors Surmodics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANGO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMajor Rollout of Social Security X?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANGO Stock Alerts